Acquisitions jump in clinical trial operations in H2
The highest value acquisition in 2021 was the $12.3m acquisition of Vifor Pharma by CSL.
By
The highest value acquisition in 2021 was the $12.3m acquisition of Vifor Pharma by CSL.
ByNuvoAir will unitise the funds to accelerate the clinical services launch with risk-bearing providers and Health Plans.
Offering quick setup timelines, the Veeva RTSM solution has so far supported more than 175 trials with sites in 60…
10 tech unicorns that are likely going enjoy a headline-making IPO in 2022, following GlobalData's predictions.
ByInnovation Fund Denmark invests in high-risk, high-potential innovation to improve the lives of the Danish population.
ByBEKHealth will use the proceeds to extend its team and meet the growing demand from clients.
The investment is the first from the fund to boost Victoria state’s mRNA manufacturing capability.
HumanFirst is expanding offerings with the new funding, as decentralised clinical trials have grown in the past year.